<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04582006</url>
  </required_header>
  <id_info>
    <org_study_id>1072.6120.196.2018-2</org_study_id>
    <nct_id>NCT04582006</nct_id>
  </id_info>
  <brief_title>Changes of Oral and Intestinal Microbiota After Bariatric Surgery</brief_title>
  <official_title>Changes of Oral and Intestinal Microbiota After Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose&#xD;
&#xD;
      The aim of this study was to analyze the changes of microbiota among patients undergoing LSG&#xD;
      or LRYGB on two levels of gastrointestinal tract (using oral swab and stool sample). We&#xD;
      compared samples from patients before and after bariatric operation.&#xD;
&#xD;
      Materials and methods This prospective cohort study was conducted in one academic, teaching&#xD;
      hospital. The recommendations of the Metabolic and Bariatric Surgery Section of the Polish&#xD;
      Surgical Society were used as indication for surgery, that is: Body Mass Index (BMI) ≥35&#xD;
      kg/m2 with obesity-related comorbidities or BMI ≥40 kg/m2.&#xD;
&#xD;
      Analysis and endpoints&#xD;
&#xD;
      Primary endpoint was to determine the difference in microbiota present in oral cavity and&#xD;
      large intestine between patients before and after bariatric surgery. Secondary endpoint was&#xD;
      to compare the difference in microbiota changes between patients undergoing LSG and LRYGB&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of microbiota in oral cavity</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of microbiota in large intestine</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>LSG</arm_group_label>
    <description>Patients undergoing laparoscopic sleeve gastrectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LRYGB</arm_group_label>
    <description>Patients undergoing laparoscopic Roux-en-Y gastric bypass.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bariatric surgery</intervention_name>
    <description>Surgical treatment of morbid obesity.</description>
    <arm_group_label>LRYGB</arm_group_label>
    <arm_group_label>LSG</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators included patients undergoing surgical treatment for morbid obesity.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  informed consent to participate in the study&#xD;
&#xD;
          -  meeting the eligibility criteria for bariatric treatment (either for LSG or LRYGB).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  treatment with antibiotics within 30 days prior to gathering microbiological material&#xD;
&#xD;
          -  gastrointestinal infections&#xD;
&#xD;
          -  inflammatory bowel disease&#xD;
&#xD;
          -  thyroid diseases&#xD;
&#xD;
          -  cancer (especially the digestive tract)&#xD;
&#xD;
          -  immunodeficiency.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>2nd Department of General Surgery, Jagiellonian University Medical College</name>
      <address>
        <city>Cracovia</city>
        <state>Małopolska</state>
        <zip>30-688</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Tomasz Stefura</investigator_full_name>
    <investigator_title>Reasearch Associate, PhD student at 2nd Department of General Surgery, Principal Investigator, Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We are not planing to share data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

